CN205181861U - Last antibiotic alginate dressing - Google Patents
Last antibiotic alginate dressing Download PDFInfo
- Publication number
- CN205181861U CN205181861U CN201520926665.5U CN201520926665U CN205181861U CN 205181861 U CN205181861 U CN 205181861U CN 201520926665 U CN201520926665 U CN 201520926665U CN 205181861 U CN205181861 U CN 205181861U
- Authority
- CN
- China
- Prior art keywords
- layer
- dressing
- alginate
- sustained anti
- microbial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The utility model relates to a belong to the medical dressing field, particularly, relate to a last antibiotic alginate dressing, a last antibiotic alginate dressing, its characterized in that from bottom to top constitutes by pasting layer, alginate sponge layer, active antibiotic layer and protective layer in proper order, and closely bonds, active antibiotic layer constitute with biological activity glass by the polyethelene alcohol fibre layer, the porous crack fibrous layer that forms by the unordered range of polyethelene alcohol fibre of polyethelene alcohol fibre layer, biological activity glass dispersion in the surface and hole on polyethelene alcohol fibre layer, be high wound diffusate, the antibiotic material of sustainable release and wound healing's the last antibiotic alginate dressing with higher speed of absorbing of an ability.
Description
Technical field
This utility model belongs to medical dressing field, in particular to a kind of sustained anti-microbial alginate dressing.
Background technology
Along with the increase of China's population aging and chronic disease, the patient of chronic wounds increases year by year.According to national survey, chronic wounds carries out the 1.5%-3.0% that hospitalization person accounts for inpatients in surgical department sum, and based on traumatic ulcer, pressure ulcer and diabetic foot ulcer, the annual expense for chronic wound care in the whole world is up to 15,000,000,000 dollars.Based on current research, traditional Dry Therapy by wound wet union theoretical substitute, the various dressing developed based on moist theory are widely used at present in the clinical practice of chronic wound care.
In prior art, the overwhelming majority is all adopt silver ion, nanometer silver as antibacterial, and it exists the risk of silver ion deposition.In addition, using argent or nanometer silver as the fiber dressing of antibacterial because silver particles is only at fiber surface, once after dressing absorbs wound exudate, these silver particles may due to surperficial moisture absorption, becomes gel or the factor such as softening and comes off.Thus cannot ensure that wound dressing sustained release goes out the antibacterial of q.s, the sick human needs of chronic wounds can not be met.
Utility model content
The purpose of this utility model is to meet the demand of medical dressing goods to high-absorbable, sustained anti-microbial and promotion chronic wound care performance, provides the sustained anti-microbial alginate wound dressing of a kind of energy high-selenium corn wound fluid, sustainable release antibiotic substance and accelerating wound healing.
The technical solution of the utility model is as follows:
A kind of sustained anti-microbial alginate dressing; from bottom to top be made up of adhered layer, alginate sponges layer, active antibacterial layer and protective layer successively; and tight bond; described active antibacterial layer is made up of vinal layer and bioactivity glass; described vinal layer is by the multi-void fiber layer of vinal lack of alignment, in the surface that described bioactivity glass is dispersed in vinal layer and hole.
Preferably, described alginate sponges layer is made up of alginic acid zinc calcium salt, is loose porous sponge structure.
Preferably, described active antibacterial layer and alginate sponges layer are bondd by electrospinning device.
Preferably, the glass-loaded amount of degradable biological of described active antibacterial layer is 0.01wt%-1wt%, and described bioactivity glass particle diameter is 500nm ~ 1um.
Preferably, described bioactivity glass is the wherein one in silicate bioactivity glass, borate biological activity glass or phosphate bioactivity glass.
Preferably, the surface area of described alginate sponges layer is equal with the surface area of active antibacterial layer and form dressing layer, the surface area of described adhered layer is greater than the surface area of dressing layer, the one side that described adhered layer contacts with dressing layer and be not coated with medical pressure-sensitive adhesive by the part that dressing covers.
Preferably, described protective layer is divided into two pages, and juxtaposition covers above dressing layer, and extends to two ends, until cover adhered layer two ends.
Preferably, described protective layer is release paper.
Preferably, described adhered layer is transparent polyurethane film.
The beneficial effects of the utility model are: (1) this utility model possesses high-absorbable performance: first active antibacterial layer contacts wound, vinal has good absorbent, the concrete dynamic modulus shape of vinal layer, is made wound fluid easily be flowed into by the hole between fiber and has stronger absorption sepage ability alginate sponges layer; (2) this utility model possesses sustained anti-microbial performance: during active antibacterial layer contact wound, the bioactivity glass on vinal surface first with Wound contact, along with vinal imbibe, bioactivity glass in vinal hole is extruded out, and sustained release is to wound location, and bioactivity glass is aobvious alkalescence, be partially formed alkaline environment, can effectively in and the acid exudate of wound surface, restrain secondary infection, reach the effect of sustained anti-microbial; (3) this utility model possesses promotion chronic wound care performance: bioactivity glass is initiatively induced epithelial cell proliferation, breaks up, divided a word with a hyphen at the end of a line, and vinal and alginate sponges layer are the effect that wound keeps moist environment, make wound quickly-healing in moist environment; (4) alginate sponges layer is prepared from by alginic acid zinc calcium salt, and its structure is loose porous in sponge structure, in use, the sodium ion of the calcium that can simultaneously discharge, zinc ion and wound carries out ion exchange, form Sodium Alginate Hydrogel Films body and siphon away a large amount of wound exudate, for wound surface provides a moistening environment, facilitate the healing of wound, its absorb transudate ability strong, there is stronger lock outlet capacity; (5) calcium of dressing release, zinc ion play the effect of hemostasis and the effective healing promoting wound to wound; (6) protective layer is divided into two pages, can tear protective layer off easily during use, brings convenience for using; (7) transparent adhered layer can observe the absorption sepage situation of alginate sponges layer in use procedure; (8) adhered layer utilizes the medical pressure-sensitive adhesive of edge coating to be pasted onto on skin, makes its not landing for fixing dressing.
Accompanying drawing explanation
Fig. 1 is the structural representation of a kind of sustained anti-microbial alginate dressing of this utility model; Description of reference numerals: 1 is adhered layer, 2 is alginate sponges layer, and 3 is active antibacterial layer, and 4 is protective layer.
Detailed description of the invention
Below in conjunction with specific embodiment, this utility model is described in detail.
In order to make the purpose of this utility model, technical scheme and advantage clearly understand, below in conjunction with embodiment, this utility model is further elaborated.Should be appreciated that specific embodiments and the drawings described herein only in order to explain this utility model, and be not used in restriction this utility model.
Embodiment:
As described in Figure, a kind of sustained anti-microbial alginate dressing, from bottom to top successively by adhered layer 1, alginate sponges layer 2, active antibacterial layer 3 and protective layer 4 are formed, and tight bond, described active antibacterial layer 3 is made up of vinal layer and bioactivity glass, described vinal layer is by the multi-void fiber layer of vinal lack of alignment, in the surface that described bioactivity glass is dispersed in vinal layer and hole, described alginate sponges layer 2 is made up of alginic acid zinc calcium salt, for loose porous sponge structure, described active antibacterial layer 3 is bondd by electrospinning device with alginate sponges layer 2, the glass-loaded amount of degradable biological of described active antibacterial layer 3 is 0.01wt%-1wt%, described bioactivity glass particle diameter is 500nm ~ 1um, described bioactivity glass is silicate bioactivity glass, wherein a kind of in borate biological activity glass or phosphate bioactivity glass, the surface area of described alginate sponges layer 2 is equal with the surface area of active antibacterial layer 3 and form dressing layer, the surface area of described adhered layer 1 is greater than the surface area of dressing layer, the one side that described adhered layer 1 contacts with dressing layer and be not coated with medical pressure-sensitive adhesive by the part that dressing covers, described protective layer 4 is divided into two pages, juxtaposition covers above dressing layer, and extend to two ends, until cover adhered layer two ends, described protective layer 4 is release paper, described adhered layer 1 is transparent polyurethane film.
It should be noted, the accompanying drawing of this description and the above description to the drawings and the specific embodiments are only for this utility model example is clearly described, are not the restrictions to embodiment of the present utility model.All do within spirit of the present utility model and principle any amendment, equivalent to replace and improvement etc., within the protection domain that all should be included in this utility model claim.
Claims (9)
1. a sustained anti-microbial alginate dressing; it is characterized in that; from bottom to top be made up of adhered layer, alginate sponges layer, active antibacterial layer and protective layer successively; and tight bond; described active antibacterial layer is made up of vinal layer and bioactivity glass; described vinal layer is by the multi-void fiber layer of vinal lack of alignment, in the surface that described bioactivity glass is dispersed in vinal layer and hole.
2. a kind of sustained anti-microbial alginate dressing according to claim 1, is characterized in that, described alginate sponges layer is made up of alginic acid zinc calcium salt, is loose porous sponge structure.
3. a kind of sustained anti-microbial alginate dressing according to claim 1, is characterized in that, described active antibacterial layer and alginate sponges layer are bondd by electrospinning device.
4. a kind of sustained anti-microbial alginate dressing according to claim 1, is characterized in that, the glass-loaded amount of degradable biological of described active antibacterial layer is 0.01wt%-1wt%, and described bioactivity glass particle diameter is 500nm ~ 1um.
5. a kind of sustained anti-microbial alginate dressing according to claim 1, is characterized in that, described bioactivity glass is the wherein one in silicate bioactivity glass, borate biological activity glass or phosphate bioactivity glass.
6. a kind of sustained anti-microbial alginate dressing according to claim 1, it is characterized in that, the surface area of described alginate sponges layer is equal with the surface area of active antibacterial layer and form dressing layer, the surface area of described adhered layer is greater than the surface area of dressing layer, the one side that described adhered layer contacts with dressing layer and be not coated with medical pressure-sensitive adhesive by the part that dressing covers.
7. a kind of sustained anti-microbial alginate dressing according to claim 6, it is characterized in that, described protective layer is divided into two pages, and juxtaposition covers above dressing layer, and extends to two ends, until cover adhered layer two ends.
8. a kind of sustained anti-microbial alginate dressing according to claim 1, is characterized in that, described protective layer is release paper.
9. a kind of sustained anti-microbial alginate dressing according to claim 1, is characterized in that, described adhered layer is transparent polyurethane film.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520926665.5U CN205181861U (en) | 2015-11-19 | 2015-11-19 | Last antibiotic alginate dressing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520926665.5U CN205181861U (en) | 2015-11-19 | 2015-11-19 | Last antibiotic alginate dressing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN205181861U true CN205181861U (en) | 2016-04-27 |
Family
ID=55774903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201520926665.5U Expired - Fee Related CN205181861U (en) | 2015-11-19 | 2015-11-19 | Last antibiotic alginate dressing |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN205181861U (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107397974A (en) * | 2017-09-11 | 2017-11-28 | 北京煜煌科技有限公司 | A kind of wound patch for treating chronic trauma |
| CN107485484A (en) * | 2017-09-01 | 2017-12-19 | 山东汉方生物科技有限公司 | Suitable for general sexual trauma, the wound of chronic trauma patch |
| CN107899061A (en) * | 2017-11-13 | 2018-04-13 | 广东泰宝医疗科技股份有限公司 | A kind of alginates wound repair dressing and preparation method thereof |
-
2015
- 2015-11-19 CN CN201520926665.5U patent/CN205181861U/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107485484A (en) * | 2017-09-01 | 2017-12-19 | 山东汉方生物科技有限公司 | Suitable for general sexual trauma, the wound of chronic trauma patch |
| CN107397974A (en) * | 2017-09-11 | 2017-11-28 | 北京煜煌科技有限公司 | A kind of wound patch for treating chronic trauma |
| CN107899061A (en) * | 2017-11-13 | 2018-04-13 | 广东泰宝医疗科技股份有限公司 | A kind of alginates wound repair dressing and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN204671391U (en) | A kind of hydrogel foam dressing | |
| CN205181861U (en) | Last antibiotic alginate dressing | |
| CN102850598B (en) | Alginate-gelatin-carboxymethylcellulose sodium blend membrane, and preparation and application thereof | |
| CN208193326U (en) | One kind prevents adhesion promoting healing combine dressing | |
| CN204655268U (en) | A kind of alginate medical dressing | |
| CN207575472U (en) | A kind of antibacterial anti hemorrhagic combine dressing | |
| CN204864218U (en) | Chitosan protects to create and applies ointment or plaster | |
| CN206026745U (en) | Anti bacteria dressing of slowly -releasing | |
| CN203647572U (en) | Composite wound applicator | |
| CN205181863U (en) | Compound dressing of alginate non -woven fabrics | |
| CN204158771U (en) | A kind of Bacterial cellulose/chitosan composite sponge dressing | |
| CN202682163U (en) | Double-layer hydrocolloid medical dressing | |
| CN210433776U (en) | Externally-used absorbable hemostatic material | |
| CN205924548U (en) | Dressing of slowly -releasing type aquogel | |
| CN207605166U (en) | A kind of novel functional foam combine dressing | |
| CN206508293U (en) | A kind of soluble stanching gauze application | |
| CN213250395U (en) | Alginate dressing | |
| CN211356244U (en) | PICC pipe is applied ointment or plaster | |
| CN211705027U (en) | Chitosan dressing with super-strong absorbability | |
| CN211797228U (en) | Medical dressing pad pasting | |
| CN203885716U (en) | Self-adhesive alginate applying patch | |
| CN208552237U (en) | A kind of compound alginates bandage | |
| CN106943232A (en) | Compound porous light strong absorptive medical absorbents | |
| CN201578446U (en) | Alginate foam dressing | |
| CN207950004U (en) | Medical air-permeable strong absorptive Multifunctional plaster |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160427 Termination date: 20211119 |